Ameriprise Financial Inc Innoviva, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 156,245 shares of INVA stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

156,245

Previous 172,405 9.37%

Holding current value

$2.72 Million

Previous $2.83 Million 6.65%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $263,892 - $323,846	-16,160 Reduced 9.37%	156,245 $3.02 Million
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $173,001 - $197,029	-12,014 Reduced 6.51%	172,405 $2.83 Million
Q1 2024 May 15, 2024	SELL	$14.56 - $16.78 $83,851 - $96,636	-5,759 Reduced 3.03%	184,419 $2.81 Million
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $131,109 - $173,145	-10,642 Reduced 5.3%	190,178 $3.05 Million
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $298,574 - $335,262	-24,137 Reduced 10.73%	200,820 $2.61 Million
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $268,154 - $323,009	-23,543 Reduced 9.47%	224,957 $2.86 Million
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $3,229 - $4,093	-301 Reduced 0.12%	248,500 $2.8 Million
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $44,887 - $52,419	-3,804 Reduced 1.51%	248,801 $3.3 Million
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $121,997 - $159,931	-10,508 Reduced 3.99%	252,605 $2.93 Million
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $441,600 - $613,059	-30,838 Reduced 10.49%	263,113 $3.88 Million
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $107,391 - $141,304	-6,978 Reduced 2.32%	293,951 $5.69 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $477,411 - $561,731	30,007 Added 11.08%	300,929 $5.19 Million
Q3 2021 Nov 15, 2021	SELL	$13.06 - $17.24 $69,779 - $92,113	-5,343 Reduced 1.93%	270,922 $4.53 Million
Q2 2021 Aug 16, 2021	SELL	$11.45 - $13.96 $42,651 - $52,001	-3,725 Reduced 1.33%	276,265 $3.71 Million
Q1 2021 May 17, 2021	BUY	$11.06 - $12.87 $142,873 - $166,254	12,918 Added 4.84%	279,990 $3.35 Million
Q4 2020 Feb 12, 2021	SELL	$9.33 - $12.48 $118,444 - $158,433	-12,695 Reduced 4.54%	267,072 $3.31 Million
Q3 2020 Nov 16, 2020	SELL	$10.33 - $14.49 $375,299 - $526,436	-36,331 Reduced 11.49%	279,767 $2.92 Million
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $166,765 - $221,483	-14,514 Reduced 4.39%	316,098 $4.42 Million
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $116,443 - $218,672	-14,358 Reduced 4.16%	330,612 $3.89 Million
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $103,519 - $144,806	-10,070 Reduced 2.84%	344,970 $4.89 Million
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $442,551 - $640,709	-44,035 Reduced 11.03%	355,040 $3.74 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $88,490 - $100,987	-6,755 Reduced 1.66%	399,075 $5.81 Million
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $77,074 - $112,937	-5,630 Reduced 1.37%	405,830 $5.69 Million
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $25,197 - $32,959	-1,805 Reduced 0.44%	411,460 $7.18 Million
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $46,478 - $53,537	3,410 Added 0.83%	413,265 $6.3 Million
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $3.88 Million - $5.08 Million	-288,585 Reduced 41.32%	409,855 $5.66 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $1.39 Million - $1.71 Million	100,591 Added 16.83%	698,440 $11.6 Million
Q4 2017 Feb 12, 2018	BUY	$11.73 - $14.75 $237,344 - $298,451	20,234 Added 3.5%	597,849 $8.48 Million
Q3 2017 Nov 07, 2017	BUY	$12.06 - $14.12 $6.97 Million - $8.16 Million	577,615	577,615 $8.16 Million

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.21B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Innoviva, Inc. Transaction History